DR. STEFANI L. CAPONE M.D. NPI 1891753729

NPI Details

DR. Stefani L. Capone, M.D. is a medical oncology internal medicine in Winter Park, FL. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Stefani L. Capone, M.D. NPI is 1891753729. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

460 N ORLANDO AVE STE 200
WINTER PARK, FL
ZIP 32789-988
Phone: (407) 898-5452

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Iron binding capacity (HCPCS:83550)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Blood test, clotting time (HCPCS:85610)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Red blood count, automated test (HCPCS:85045)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Red blood count, manual test (HCPCS:85044)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of drug or substance into vein (HCPCS:96374)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Magnesium level (HCPCS:83735)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)

The enumeration date for this NPI number is 5/2/2006 and was last updated on 9/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.